Bayesian Capital Management’s Smith & Wesson SWBI Stock Holding History

Bayesian Capital Management’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,642	Closed	-$237K	–	1080
2024 Q1	$237K	Buy	+13,642	New	+$197K	0.02%	622
2023 Q4	–	Sell	-19,700	Closed	-$254K	–	1017
2023 Q3	$254K	Buy	+19,700	New	+$246K	0.03%	509
2022 Q4	–	Sell	-21,056	Closed	-$218K	–	1024
2022 Q3	$218K	Sell	21,056 -11,744	-36%	-$155K	0.04%	508
2022 Q2	$431K	Buy	+32,800	New	+$476K	0.08%	371
2019 Q3	–	Sell	-33,847	Closed	-$234K	–	678
2019 Q2	$234K	Buy	+33,847	New	+$240K	0.05%	415
2019 Q1	–	Sell	-108,113	Closed	-$1.07M	–	739
2018 Q4	$1.07M	Buy	108,113 +64,139	+146%	+$666K	0.22%	143
2018 Q3	$525K	Buy	+43,974	New	+$398K	0.09%	321
2017 Q3	–	Sell	-17,043	Closed	-$290K	–	627
2017 Q2	$290K	Buy	+17,043	New	+$294K	0.11%	298

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bayesian Capital Management's SWBI Position: Q2 2024 in Review

Bayesian Capital Management sold out of Smith & Wesson (SWBI) in Q2 2024, closing a stake of 13,642 shares — an estimated $237K sold.

Bayesian Capital Management first reported a position in SWBI in Q2 2017 and held it in 8 quarters. The position peaked at $1.07M in Q4 2018. 194 funds tracked by Wall St. Rank hold SWBI as of Q2 2024.

Bayesian Capital Management reported no remaining Smith & Wesson position as of Q2 2024 after selling out during the quarter.
Bayesian Capital Management sold 13,642 Smith & Wesson shares in Q2 2024, an estimated $237K.
Bayesian Capital Management first reported a position in Smith & Wesson in Q2 2017 and held it in 8 quarters.
Bayesian Capital Management's Smith & Wesson position peaked at $1.07M in Q4 2018.
194 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.